Shareholding disclosure

Investor AB

Declared position

9.37%

Threshold

Crossed upwards

Timeline

Published

04.10.2017

Transaction

03.10.2017

Voting rights breakdown

Voting rights acquired9.37%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAHA2000A8

Beneficial owner

Investor AB

Declared address

Investor AB, Stockholm

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Investor AB

Newron Pharmaceuticals S.p.A.04.10.2017TAHA2000A8

Disclosure summary

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 04.10.2017, at 9.37% of voting rights. Notice category: Single shareholder.

Disclosed position

9.37%

Voting rights acquired

Voting rights acquired9.37%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A., published on 04.10.2017.

Publication date04.10.2017

Transaction date03.10.2017

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerInvestor AB

Declared addressInvestor AB, Stockholm

CategorySingle shareholder

Voting rights acquired9.37%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAHA2000A8

Source: SIX Exchange Regulation · Publication date: 04.10.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open